Duobrii

Product manufactured by Bausch Health Us, Llc

Application Nr Approved Date Route Status External Links
NDA209354 None Topical None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Duobrii ® (halobetasol Propionate And Tazarotene) Lotion, 0.01%/0.045% Is Indicated For The Topical Treatment Of Plaque Psoriasis In Adults. Duobrii Lotion Is A Combination Of Halobetasol Propionate And Tazarotene Indicated For The Topical Treatment Of Plaque Psoriasis In Adults. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 2 Total)

Name Structure ZINC ID(s)
1. Halobetasol Propionate
2. Tazarotene TAZAROTENE ZINC1542199

Comments